Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Rev Esp Enferm Dig ; 105(3): 171-4, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23735026

RESUMO

Collagenous sprue is a rare disease of the small bowel characterized by mucosal atrophy and excessive subepithelial collagen deposition. The etiology remains unclear and the diagnosis is based upon patient´s clinical picture and anatomopathological findings. Clinically, collagenous sprue is characterized by persistent diarrhoea, severe malabsorption, multiple nutrient deficiencies and progressive weight loss. Differential diagnosis includes celiac disease, which is mandatory to rule out because of their frequent association. Glutenfree diet is the first therapeutic step, but it usually is not effective. However, recent studies show high success rates with immunomodulators, mainly corticosteroids. We report the case of a patient presenting with chronic diarrhea and severe malabsorption who was diagnosed with collagenous sprue, with no response to gluten free diet, but with excellent response to budesonida.


Assuntos
Espru Colágeno/diagnóstico , Idoso de 80 Anos ou mais , Doença Crônica , Espru Colágeno/complicações , Tecido Conjuntivo , Diarreia/etiologia , Humanos , Masculino
4.
Gastroenterol Hepatol ; 30(4): 232-3, 2007 Apr.
Artigo em Espanhol | MEDLINE | ID: mdl-17408553

RESUMO

The application of recombinant human granulocyte colony-stimulating factor (filgrastim) seems to be a safe, well tolerated and potentially effective therapy for active Crohn's disease. We report the case of an adolescent boy with Crohn's disease and intra-abdominal abscess associated who had a significant response to treatment with recombinant human granulocyte colony-stimulating factor after all standard treatments had failed.


Assuntos
Abscesso Abdominal/etiologia , Doença de Crohn/tratamento farmacológico , Fator Estimulador de Colônias de Granulócitos/uso terapêutico , Adulto , Antibacterianos/uso terapêutico , Anticorpos Monoclonais/uso terapêutico , Azatioprina/uso terapêutico , Diferenciação Celular , Terapia Combinada , Doença de Crohn/imunologia , Doença de Crohn/patologia , Doença de Crohn/cirurgia , Citocinas/biossíntese , Resistência a Medicamentos , Filgrastim , Humanos , Imunossupressores/efeitos adversos , Imunossupressores/uso terapêutico , Infliximab , Macrófagos/patologia , Masculino , Metotrexato/efeitos adversos , Metotrexato/uso terapêutico , Neutrófilos/efeitos dos fármacos , Prednisona/efeitos adversos , Prednisona/uso terapêutico , Proteínas Recombinantes , Fator de Necrose Tumoral alfa/biossíntese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA